Role of recombinant human glicentin in the normal human jejunum: An in vitro study

Hepato-Gastroenterology

Volumn 52, Issue 65, 2005, Pages 1459-1462

  Tomita, Ryouichi ^a,b   Igarashi, Seigo ^a   Tanjoh, Katuhisa ^a   Fujisaki, Shigeru ^a  

^a NIPPON DENTAL UNIVERSITY   (Japan)

^b NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Enteric nervous system; Glicentin; Normal human colon

Indexed keywords

GLICENTIN; RECOMBINANT HORMONE; RECOMBINANT HUMAN GLICENTIN; TETRODOTOXIN; UNCLASSIFIED DRUG;

ADRENERGIC NERVE; ADULT; AGED; ARTICLE; AUTONOMIC NERVE; CHOLINERGIC NERVE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; HORMONE ACTION; HUMAN; HUMAN TISSUE; IN VITRO STUDY; INTESTINE CONTRACTION; INTESTINE INNERVATION; INTESTINE MUSCLE; JEJUNUM; MALE; MUSCLE EXCITATION; NERVE BLOCK; NEUROMODULATION; PRIORITY JOURNAL; STOMACH CANCER;

AGED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLICENTIN; GLUCAGON; GLUCAGON-LIKE PEPTIDES; HUMANS; JEJUNUM; MALE; MIDDLE AGED; MUSCLE CONTRACTION; MUSCLE, SMOOTH; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RECOMBINANT PROTEINS; TETRODOTOXIN;

EID: 25844462858     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Unger RH, Ketterer H, Eisentraut: Distribution of immunoassayable glucagon in gastrointestinal tissues. Metabolism 1996; 15:865-867.
2. Sundby F, Jacobsen H, Moody AJ: Purification and characterization of a protein from porcine gut with glucagon-like immunoreactivity. Horm Metab Res 1996; 8:366-371.
3. Thim L, Moody AJ: The primary structure of porcine glicentin (proglucagon). Regul Pept 1981; 2:139-150.
4. Kirkegaard P, Moody AJ, Holst JJ, Loud FB, Skov Olsen P, Christiansen J: Glicentin inhibits gastric acid secretion in the rat. Nature 1982; 297:156-157.
5. Imai S, Sasaki K, Satoh T, Oomori T, Iwata N, Yanaihara N, Natori Y: Production of human glicentin in Escherichia coli. Biomed Res 1996; 17:279-285.
6. Naito H, Ohneda A, Kojima R, Sato T, Sasaki K, Funayama Y, Fukushima K, Shibata C, Matsuno S, Sasaki I: Plasma glicentin in diabetic and gastrectomized patients. Regul Pept 1999; 79:55-61.
7. Kodier G, Le Nguyen D, Bataille D, Jarrousse C: Effect of glicentin, oxytomodulin and related peptides on isolated gastric smooth muscle cells. Eur J Physiol 1997; 434:729-734.
8. Tomita R: Study on the relationship between vasoactive intestinal polypeptide (VIP) and the non-adrenergic non-cholinergic nerve in human intestine. J Nihon Univ Med Ass 1981; 40:1-12. (In Japanese)
9. Tomita R, Tanjoh K, Fujisaki S, Fukuzawa M: Physiological studies on nitric oxide in the right colon of patients with diverticular disease. Hepatogastroenterology 1999; 46:2839-2844.
10. Garaud JC, Eloy R, Moody AJ, Stock C, Grenier JF: Glucagon- and glicentin-immunoreactive cells in the human digestive tract. Cell Tissue Res 1980; 213:121-136.
11. Blache P, Kervran A, Bataille D: Oxyntomodulin and glicentin: Brain-gut peptides in the rat. Endocrinol 1988; 123:2782-2787.
12. Myojo S, Tsujikawa T, Sasaki M, Fujiyama Y, Bamba T: Trophic effects of glicentin on rat small-intestinal mucosa in vivo and in vitro. J Gastroenterol 1997; 32:300-305.
13. Genevieve R, Magous R, Mochizuki T, Nguyen DL, Martinez J, Bali JP, Bataille D, Jarrousse C: Glicentin and oxyntomodulin modulate both the phosphoinositide and cyclic adenosine monophosphate signaling pathways in gastric myocytes. Endocrinology 1999; 140:22-28.
14. Ohneda A, Ohneda K, Nagasaki T, Sasaki K: Insulinotropic action of human glicentin in dogs. Metabolism 1995; 44:47-45.
15. Ohtani N, Sasaki I, Naitoh H: Inhibitory effect of peptide YY, neurotensin and glicentin on upper gastrointestinal motility in dogs. Biomed Res 1994; 15:300-305.
16. Libsch KD, Duininck TM, Sarr MG: Heal resection enhances jejunal absorptive adaptation for water and electrolytes to extrinsic denervation: implications for segmental small bowel. Transplantation 2003; 38:502-507.
17. Tomita R, Tanjoh K, Fujisaki S, Ikeda T, Fukuzawa M: Regulation of the enteric nervous system in the colon of patients with slow transit constipation. Hepatogastroenterology 2002; 49:1544-1540.
18. Tomita R, Fujisaki S, Park E, Kimizuka K, Fukuzawa M: Physiological studies of enteric nervous system in the rat small bowel isografts. Transplant Proc 2002; 34:1019-1020.
19. Katsuta T: Role of glicentin in intestinal adaptation to massive small bowel resection. J Nihon Univ Med Ass 1986; 45:683-693. (In Japanese)
20. Chiba M, Sanada Y, Tsunoda Y, Yosizawa Y, Nemoto H, Okamatsu T: Proliferative effect of glicentin on human intestinal epithelial cells. J Jpn Soc Pediatr Surg 1998; 34:1155-1161. (In Japanese)
21. Tomita R, Tanjoh K, Fujisaki S, Fukuzawa M: Peptidergic nerves in the colon of patients with ulcerative colitis. Hepatogastroenterology 2000; 32:400-404.
22. Seguy D, Vahedi K, Kapel N, Souberbielle JC, Messing B: Low-dose growth hormone in adult home parenteral nutrition-dependent short bowel syndrome patients: A positive study. Gastroenterology 2003; 124:293-302.